Susquehanna International Group’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.4K | Buy |
+11,600
| New | +$39.4K | ﹤0.01% | 12747 |
|
|
2025
Q4 | – | Sell |
-63,400
| Closed | -$235K | – | 12694 |
|
|
2025
Q3 | $235K | Buy |
63,400
+49,600
| +359% | +$125K | ﹤0.01% | 10638 |
|
|
2025
Q2 | $25.7K | Sell |
13,800
-19,500
| -59% | -$33.8K | ﹤0.01% | 12277 |
|
|
2025
Q1 | $51.9K | Buy |
+33,300
| New | +$58.7K | ﹤0.01% | 11847 |
|
|
2024
Q4 | – | Sell |
-21,900
| Closed | -$31.8K | – | 12483 |
|
|
2024
Q3 | $31.8K | Sell |
21,900
-25,900
| -54% | -$49.3K | ﹤0.01% | 11520 |
|
|
2024
Q2 | $81.7K | Sell |
47,800
-28,500
| -37% | -$51.7K | ﹤0.01% | 11156 |
|
|
2024
Q1 | $153K | Buy |
76,300
+21,400
| +39% | +$42.6K | ﹤0.01% | 10888 |
|
|
2023
Q4 | $165K | Buy |
54,900
+49,180
| +860% | +$130K | ﹤0.01% | 10876 |
|
|
2023
Q3 | $24.9K | Buy |
5,720
+2,280
| +66% | +$15.6K | ﹤0.01% | 11541 |
|
|
2023
Q2 | $28.4K | Buy |
+3,440
| New | +$34K | ﹤0.01% | 11534 |
|
|
2022
Q3 | – | Sell |
-7,133
| Closed | -$90K | – | 13434 |
|
|
2022
Q2 | $90K | Sell |
7,133
-500
| -7% | -$7.41K | ﹤0.01% | 11562 |
|
|
2022
Q1 | $156K | Sell |
7,633
-1,874
| -20% | -$51.3K | ﹤0.01% | 11522 |
|
|
2021
Q4 | $357K | Sell |
9,507
-1,146
| -11% | -$51.1K | ﹤0.01% | 10062 |
|
|
2021
Q3 | $515K | Buy |
10,653
+3,800
| +55% | +$185K | ﹤0.01% | 9331 |
|
|
2021
Q2 | $367K | Buy |
+6,853
| New | +$413K | ﹤0.01% | 10335 |
|
|
2018
Q2 | – | Sell |
-1,207
| Closed | -$82K | – | 9818 |
|
|
2018
Q1 | $82K | Buy |
+1,207
| New | +$76.4K | ﹤0.01% | 8775 |
|
|
2017
Q4 | – | Sell |
-1,500
| Closed | -$99K | – | 9412 |
|
|
2017
Q3 | $99K | Buy |
+1,500
| New | +$101K | ﹤0.01% | 8362 |
|
|
2017
Q2 | – | Sell |
-1,367
| Closed | -$76K | – | 9345 |
|
|
2017
Q1 | $76K | Sell |
1,367
-5,520
| -80% | -$247K | ﹤0.01% | 8489 |
|
|
2016
Q4 | $279K | Buy |
+6,887
| New | +$257K | ﹤0.01% | 8106 |
|
|
2016
Q3 | – | Sell |
-1,713
| Closed | -$69K | – | 8566 |
|
|
2016
Q2 | $69K | Sell |
1,713
-480
| -22% | -$22.4K | ﹤0.01% | 8166 |
|
|
2016
Q1 | $102K | Buy |
+2,193
| New | +$92.5K | ﹤0.01% | 8419 |
|
|
2015
Q3 | – | Sell |
-2,253
| Closed | -$114K | – | 9736 |
|
|
2015
Q2 | $114K | Sell |
2,253
-5,647
| -71% | -$290K | ﹤0.01% | 9621 |
|
|
2015
Q1 | $456K | Sell |
7,900
-11,780
| -60% | -$491K | ﹤0.01% | 7255 |
|
|
2014
Q4 | $720K | Sell |
19,680
-327
| -2% | -$9.63K | ﹤0.01% | 6501 |
|
|
2014
Q3 | $630K | Buy |
20,007
+4,820
| +32% | +$128K | ﹤0.01% | 6792 |
|
|
2014
Q2 | $392K | Buy |
15,187
+1,034
| +7% | +$27.3K | ﹤0.01% | 7928 |
|
|
2014
Q1 | $420K | Buy |
14,153
+3,293
| +30% | +$128K | ﹤0.01% | 7024 |
|
|
2013
Q4 | $428K | Sell |
10,860
-160
| -1% | -$6.18K | ﹤0.01% | 6994 |
|
|
2013
Q3 | $1.16M | Buy |
11,020
+7,727
| +235% | +$947K | ﹤0.01% | 5026 |
|
|
2013
Q2 | $425K | Buy |
+3,293
| New | +$486K | ﹤0.01% | 6286 |
|
Other funds holding FBIO
OM
VCM
SAM
GCP
BCM
Susquehanna International Group's FBIO Position: Q1 2026 in Review
Susquehanna International Group reduced its Fortress Biotech (FBIO) stake by 8.3% in Q1 2026, selling an estimated $64.7K and leaving 210,745 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #9242.
Susquehanna International Group first reported a position in FBIO in Q2 2013 and has held it in 31 quarters since. The position peaked at $1.32M in Q3 2025. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Susquehanna International Group held 210,745 shares of Fortress Biotech worth $588K as of Q1 2026.
- Susquehanna International Group sold 19,032 Fortress Biotech shares in Q1 2026, an estimated $64.7K.
- Fortress Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9242 holding.
- Susquehanna International Group first reported a position in Fortress Biotech in Q2 2013 and has held it in 31 quarters since.
- Susquehanna International Group's Fortress Biotech position peaked at $1.32M in Q3 2025.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.